165 related articles for article (PubMed ID: 27976709)
1. Evaluation of efficacy and safety for recombinant human adenovirus-p53 in the control of the malignant pleural effusions via thoracic perfusion.
Biaoxue R; Hui P; Wenlong G; Shuanying Y
Sci Rep; 2016 Dec; 6():39355. PubMed ID: 27976709
[TBL] [Abstract][Full Text] [Related]
2. Thoracic perfusion of recombinant human endostatin (Endostar) combined with chemotherapeutic agents versus chemotherapeutic agents alone for treating malignant pleural effusions: a systematic evaluation and meta-analysis.
Biaoxue R; Xiguang C; Hua L; Wenlong G; Shuanying Y
BMC Cancer; 2016 Nov; 16(1):888. PubMed ID: 27842514
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of efficacy and safety for Brucea javanica oil emulsion in the control of the malignant pleural effusions via thoracic perfusion.
Fuhong D; Xiang G; Haiying L; Jiangye W; Xueming G; Wenxiao C
BMC Cancer; 2018 Apr; 18(1):411. PubMed ID: 29649989
[TBL] [Abstract][Full Text] [Related]
4. Thoracic perfusion of recombinant mutant human tumor necrosis factor (rmhTNF) can be considered as a good adjunct in the treatment of malignant pleural effusion caused by lung cancer.
Fu T; Lin Y; Zeng Q; Yao W; Han L
BMC Pulm Med; 2020 Jun; 20(1):175. PubMed ID: 32552897
[TBL] [Abstract][Full Text] [Related]
5. [Clinical research on recombinant human Ad-p53 injection combined with cisplatin in treatment of malignant pleural effusion induced by lung cancer].
Zhao WZ; Wang JK; Li W; Zhang XL
Ai Zheng; 2009 Dec; 28(12):1324-7. PubMed ID: 19958629
[TBL] [Abstract][Full Text] [Related]
6. Advanced malignant pleural or peritoneal effusion in patients treated with recombinant adenovirus p53 injection plus cisplatin.
Dong M; Li X; Hong LJ; Xie R; Zhao HL; Li K; Wang HH; Shin WD; Shen HJ
J Int Med Res; 2008; 36(6):1273-8. PubMed ID: 19094436
[TBL] [Abstract][Full Text] [Related]
7. p53 gene therapy-based transarterial chemoembolization for unresectable hepatocellular carcinoma: A prospective cohort study.
Shen A; Liu S; Yu W; Deng H; Li Q
J Gastroenterol Hepatol; 2015 Nov; 30(11):1651-6. PubMed ID: 25968838
[TBL] [Abstract][Full Text] [Related]
8. Thoracic perfusion of lobaplatin combined with endostar for treating malignant pleural effusions: A meta-analysis and systematic review.
Wang CQ; Liu FY; Wang W
Medicine (Baltimore); 2022 Oct; 101(40):e30749. PubMed ID: 36221355
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Efficacy and Safety for Lentinan in the Control of the Malignant Pleural Effusions via Intrapleural Injection.
Congcong Q; Hengting Z; Shuhui L; Fang Y; Shan W
Am J Med Sci; 2019 Dec; 358(6):400-411. PubMed ID: 31813467
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Efficacy and Safety for Kanglaite Injection in the Control of the Malignant Pleural Effusions via Thoracic Perfusion: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Zhu G; Wang X; Li J; Zhang Y; Gao R; Zhang X; Xu B; Hu J; Dai M; Chen J
Front Pharmacol; 2021; 12():694129. PubMed ID: 34803667
[No Abstract] [Full Text] [Related]
11. Efficacy of recombinant adenoviral human p53 gene in treatment of malignant pleural or peritoneal effusions.
Zhang X; Hu Y; Wang J; Zhang S; Tao H; Jing S; Wu B
Zhongguo Fei Ai Za Zhi; 2013 Mar; 16(3):153-6. PubMed ID: 23514945
[TBL] [Abstract][Full Text] [Related]
12. [A Meta-Analysis of Efficacy and Adverse Effects of Lobaplatin and Cisplatin in the Treatment of Malignant Pleural Effusion].
Min S; Zheng Q; Zhang B; Yan D; Wang R; Qu Z; Li L; Liu J; Zhou Q
Zhongguo Fei Ai Za Zhi; 2019 Feb; 22(2):90-98. PubMed ID: 30827325
[TBL] [Abstract][Full Text] [Related]
13. Thoracic injection of low-dose interleukin-2 as an adjuvant therapy improves the control of the malignant pleural effusions: a systematic review and meta-analysis base on Chinese patients.
Han L; Jiang Q; Yao W; Fu T; Zeng Q
BMC Cancer; 2018 Jul; 18(1):725. PubMed ID: 29980186
[TBL] [Abstract][Full Text] [Related]
14. Recombinant adenovirus p53 combined with radiotherapy improves efficacy and safety in the treatment of head and neck lymphoma.
Xu YH; Liu SH; Hao FR; Zhang YH
Cancer Biomark; 2018; 23(2):213-220. PubMed ID: 30198865
[TBL] [Abstract][Full Text] [Related]
15. Effect and Safety of Recombinant Adenovirus-p53 Transfer Combined with Radiotherapy on Long-Term Survival of Locally Advanced Cervical Cancer.
Su X; Chen WJ; Xiao SW; Li XF; Xu G; Pan JJ; Zhang SW
Hum Gene Ther; 2016 Dec; 27(12):1008-1014. PubMed ID: 27575731
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of intrapleural perfusion with hyperthermic chemotherapy for malignant pleural effusion: a meta-analysis.
Pan X; Hou Z; Zhang T; Ding Z; Ye F; Wang Z; Huang C; Wang P; Li X
J Cardiothorac Surg; 2024 May; 19(1):278. PubMed ID: 38711077
[TBL] [Abstract][Full Text] [Related]
17. Applications of Recombinant Adenovirus-p53 Gene Therapy for Cancers in the Clinic in China.
Xia Y; Li X; Sun W
Curr Gene Ther; 2020; 20(2):127-141. PubMed ID: 32951572
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of recombinant human adenovirus p53 combined with chemoradiotherapy in the treatment of recurrent nasopharyngeal carcinoma.
Ma WS; Ma JG; Xing LN
Anticancer Drugs; 2017 Feb; 28(2):230-236. PubMed ID: 27775992
[TBL] [Abstract][Full Text] [Related]
19. Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancer‑mediated malignant pleural effusion.
Du N; Li X; Li F; Zhao H; Fan Z; Ma J; Fu Y; Kang H
Oncol Rep; 2013 Jun; 29(6):2332-40. PubMed ID: 23525453
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and safety of human type 5 recombinant adenovirus (H101) in malignant tumor with malignant pleural effusion and ascites: A multicenter, observational, real-world study.
Wang B; Zhong C; Liao Z; Wang H; Cai X; Zhang Y; Wang J; Wang T; Yao H
Thorac Cancer; 2023 Oct; 14(30):3051-3057. PubMed ID: 37675621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
